Whole-exome sequencing has recently led to the discovery of mutations in another gene, topoisomerase DNA II binding protein 1 (TopBP1), also involved in PAH susceptibility [261]. The gene discussed is TOPBP1; the disease is pulmonary arterial hypertension.